Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
Generated Narrative: Evidence 104394
version: 9; Last updated: 2023-12-06 00:46:56+0000
Profiles: ComparatorOnlyEvidence, SingleStudyEvidence
url: https://fevir.net/resources/Evidence/104394
identifier: FEvIR Object Identifier/104394
name: ComparatorOnlyEvidence_Treatment_with_opioids_without_bariatric_surgery_Control_Group_in_JAMA_2018_Norwegian_cohort_study
title: ComparatorOnlyEvidence: Treatment with opioids without bariatric surgery (Control Group) in JAMA 2018 Norwegian cohort study
status: Active
date: 2022-09-19 21:15:10+0000
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
author: Brian S. Alper:
Code | Value[x] |
Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence Communication | ComparatorOnlyEvidence |
Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence Communication | SingleStudyEvidence |
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
relatedArtifact
type: Derived From
Documents
Url https://jamanetwork.com/journals/jama/fullarticle/2669729
relatedArtifact
type: Cite As
citation:
ComparatorOnlyEvidence: Treatment with opioids without bariatric surgery (Control Group) in JAMA 2018 Norwegian cohort study [Evidence]. Contributors: In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 104394. Revised 2022-09-19. Available at: https://fevir.net/resources/Evidence/104394. Computable resource at: https://fevir.net/resources/Evidence/104394.
description:
Risk of Treatment with opioids in control group was 15.8%.
variableDefinition
description:
Cohort study with baseline data of exposures from November 2005 through July 2010 and follow-up data from 2006 until death or through December 2015 at a tertiary care outpatient center, Vestfold Hospital Trust, Norway. Consecutive treatment-seeking adult patients (n = 2109) with severe obesity assessed (221 patients excluded and 1888 patients included). -- Comparator Group assigned to no bariatric surgery (specialized medical treatment without bariatric surgery (control group))
variableRole: Population
observed: ComparatorGroup: JAMA 2018 Norwegian cohort study Control cohort
variableDefinition
description:
Treatment with opioids
variableRole: Outcome
observed: OutcomeVariable: Treatment with opioids
synthesisType: not applicable
studyDesign: Observational research, Parallel cohort design, Longitudinal data collection
statistic
description:
151 out of 956 observed with percentage of: 15.8%
statisticType: Proportion
quantity: 0.158
numberAffected: 151
SampleSizes
NumberOfStudies NumberOfParticipants KnownDataCount 1 956 956